Showing results (1221-1230 of 1,626) with videos related to
Sort By:
Pageof 163
Neurocritical Care|November 15, 2015
The Prognostic Value of 48-h Continuous EEG During Therapeutic Hypothermia After Cardiac ArrestMarta Lamartine Monteiro, Fabio Silvio Taccone, Chantal Depondt, et al.Surgical Endoscopy|January 5, 2021
Double-clip traction could be superior to the pocket-creation method with cylindrical cap for colonic ESD: a randomized study in an ex vivo modelJérémie Albouys, Martin Dahan, Hugo Lepetit, et al.The Journal of Pharmacology and Experimental Therapeutics|October 28, 2021
A putative new melatonin binding site in sheep brain, MTx: preliminary observations and characteristicsPreety Shabajee-Alibay, Anne Bonnaud, Benoit Malpaux, et al.Revue Medicale De Liege|July 8, 1999
[Successful PMA. Review of the activities of the Center for Medically Assisted Procreation of University of Liege, 1985-1997]M Dubois, C Jouan, F Thonon, et al.Journal of Periodontology|October 26, 1999
Culture of gingival fibroblasts on bioabsorbable regenerative materials in vitroF Simain-Sato, J Lahmouzi, G K Kalykakis, et al.The Journal of Clinical Endocrinology and Metabolism|March 25, 2010
Sleep disturbances, daytime sleepiness, and quality of life in adults with growth hormone deficiencyGeorges Copinschi, Arlet Nedeltcheva, Rachel Leproult, et al.European Journal of Pharmacology|December 29, 2011
Molecular pharmacology of the mouse melatonin receptors MT₁ and MT₂Séverine Devavry, Céline Legros, Chantal Brasseur, et al.Plos One|June 25, 2014
Recombinant human melatonin receptor MT1 isolated in mixed detergents shows pharmacology similar to that in mammalian cell membranesChristel Logez, Sylvie Berger, Céline Legros, et al.L'Encephale|March 15, 2025
Usefulness in rehabilitation of the paper Multiple Errands Test to assess executive functions in patients with schizophrenia, bipolar or autism disorders. Results from the REHABase cohort studyDenis Boucaud-Maitre, Julien Plasse, Isabelle Chéreau-Boudet, et al.Bulletin Du Cancer|December 13, 2023
[Optimizing the use of bosutinib in patients with chronic-phase chronic myeloid leukemia: Recommendations of a panel of experts from the Fi-LMC (French CML working group)]Delphine Rea, Emilie Cayssials, Aude Charbonnier, et al.Pageof 163